Open Access
CC BY-NC-ND 4.0 · Endosc Int Open 2019; 07(02): E186-E188
DOI: 10.1055/a-0764-4736
Case report
Owner and Copyright © Georg Thieme Verlag KG 2019

Alcohol-free EUS-guided chemoablation of multiple pancreatic insulinomas

Daniel Gaballa
1   Department of Internal Medicine, Division of Gastroenterology, Penn State University Hospital, Hershey Medical Center, Hershey, Pennsylvania, United States
,
Catherine S. Abendroth
2   Department of Pathology, Division of Anatomic Pathology, Penn State University Hospital, Hershey Medical Center, Hershey, Pennsylvania, United States
,
Matthew T. Moyer
1   Department of Internal Medicine, Division of Gastroenterology, Penn State University Hospital, Hershey Medical Center, Hershey, Pennsylvania, United States
› Author Affiliations
Further Information

Publication History

submitted13 February 2018

accepted after revision25 June 2018

Publication Date:
18 January 2019 (online)

Preview

Abstract

Background and study aims Endoscopic ultrasound (EUS)-guided chemoablation with ethanol lavage, followed by infusion with paclitaxel, has been found to be effective for treatment of mucinous pancreatic cysts. However, there are notable adverse events (AEs) associated with ethanol and its undesirable inflammatory effects on local tissue and vessels. The recent ChARM trial demonstrated that removing ethanol from the cyst ablation process resulted in equivalent efficacy while significantly reducing associated AEs. Encouraged by these results, we speculated that alcohol-free chemoablation can be applied to treatment of solid tumors, as described in our case with a patient with severe and symptomatic recurrent hypoglycemia in the setting of multifocal insulinomas. As a result, the patient saw a significant reduction in symptoms. EUS-guided alcohol-free chemoablation may represent a new alternative to previously established therapies that will ultimately reduce risk of AEs.